Depending on dose, 64100% of retatrutide-treated individuals achieved at least 5% weight loss (a common benchmark for clinical success) versus 27% on placebo
As you lose weight, your TDEE drops, so a deficit set at your starting weight gets smaller over time
Here's what we'll cover Key takeaways Ozempic (semaglutide) has several alternatives, including other GLP-1 receptor agonists approved by the US Food and Drug Administration (FDA)
Cardiometabolic research (hypertension, dyslipidemia, cardiovascular diseases): Investigated for effects on blood pressure regulation, lipid metabolism, cholesterol control, and prevention of major adverse cardiovascular events in patients with diabetes and obesity
94 The lixisenatide group demonstrated significant advantages in both glycemic control and liver fibrosis prediction indicators, such as the AST to platelet ratio index